InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Thursday, 11/05/2015 10:26:50 AM

Thursday, November 05, 2015 10:26:50 AM

Post# of 462062
This is from the abstract I just downloaded from the CTAD site;

"A significant majority of all patients tested so far improved their
respective MMSE score.
The average EEG/ERP (P300 amplitude)
signal also improved and also the average Cogstate test improved
across the test batteries. Conclusions: Data collected so far indicate
that ANAVEX 2-73 is safe and well tolerated. Interim results also
show improved cognitive performance after drug administration in
subjects with mild-to-moderate AD. The current results seem to justify
a prospective comparison with current standard of care in a larger"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News